J9360 HCPCS code: Injection, vinblastine sulfate, 1 mg
J9360 is the HCPCS Level II code for injection, vinblastine sulfate, 1 mg. In 2024 Medicare paid an average of $3.38 per service for J9360 across 22,142 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 45 per day on DME suppliers. Medicare volume fell 14% from 2022 to 2024 (25,744 to 22,142 services). In 2024, about 665 clinicians billed Medicare for J9360 for 413 beneficiaries; Florida, Texas, California accounted for 47% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1986-01-01 |
| Last action effective | 2009-01-01 |
Who bills J9360 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 665 |
| Medicare beneficiaries | 413 |
| States with claims | 15 |
| Share of services in top 3 states (Florida, Texas, California) | 47% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9360, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 25,744 | 498 | $3.90 | $3.11 |
| 2023 | 23,830 | 459 | $3.90 | $3.09 |
| 2024 | 22,142 | 413 | $4.25 | $3.38 |
States with the most J9360 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 3,114 | $3.41 |
| Texas | 2,236 | $3.51 |
| California | 2,045 | $3.46 |
| Illinois | 1,499 | $3.37 |
| New York | 1,250 | $3.42 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 45 | Clinical: CMS Workgroup |
| outpatient hospital claims | 40 | Prescribing Information |
| practitioner claims | 40 | Prescribing Information |
What changed for J9360
- 1986-01-01: J9360 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9360?
J9360 is the HCPCS Level II code for injection, vinblastine sulfate, 1 mg. Short descriptor: "Vinblastine sulfate inj".
How much does Medicare pay for J9360?
In 2024, the average Medicare payment was $3.38 per service (average allowed $4.25).
Does Medicare cover J9360?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J9360 can be billed per day?
45 on DME suppliers; 40 on outpatient hospital claims; 40 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9360
- Watch J9360 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9360
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.